Consistent with this, in breast cancer patients, the expression of both CSF-1 and its receptor in neoplastic epithelial cells strongly correlates with poor prognosis and is predictive of ipsilateral recurrence [18]–[20]. Here, CSF1 is linked to breast cancer.